GaldermaReceivesU.S.FDAApprovalforDifferin庐Epiduo庐AcneGelPrescription-to-OTCSwitch
===2026/5/26 0:28:20===
D-CERTIFIED DERMATOLOGIST
UNITED STATES
First approved as a prescription treatment, Epiduo® (Adapalene 0.1% and Benzoyl Peroxide 2.5%) Gel has been trusted by dermatologists for more than 15 years, with millions of prescriptions written worldwide. Its global clinical legacy includes more than ten Galderma studies involving over 3,200 patients, along with extensive third-party studies, across a wide range of ages, skin tones and acne severity. With this Prescription-to-OTC switch, Galderma continues to play a defining role in shaping modern acne care, leveraging its own proprietary science to advance dermatology, and expanding access to effective treatments.
Differin Epiduo will be available over-the-counter at most major retailers, including Walmart, Ulta, Target and Amazon, beginning in the summer of 2026.
=*=*=*=*=*=
当前为第7/10页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页